Company pledges $1 million for UBC to study marijuana's effect on HIV (BC Centre for Excellence in HIV/AIDS)
A company vying for a licence to produce and sell medical marijuana has pledged $1 million to a University of British Columbia researcher studying pot's potential for treating HIV-AIDS.
National Green Biomed Ltd. was founded by a group including former Liberal MP Herb Dhaliwal and private investment banker David Sidoo, who is also a member of the UBC Board of Governors.
Dr. Julio Montaner, head of the UBC Division of AIDS and director of the B.C. Centre for Excellence in HIV/AIDS, said some patients have reported benefiting from using cannabis.
Canadian Press reports
Ken, cardiac patient